CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.
Journal Information
Full Title: Metab Brain Dis
Abbreviation: Metab Brain Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest Prof MJ Kotze is a director and shareholder of Gknowmix (Pty) Ltd. that has developed a database tool for research translation under the auspices of the Innovation Centre of the South African Medical Research Council."
"The authors gratefully acknowledge the financial support provided by the Cancer Association of South Africa (CANSA), the Harry Crossley Foundation and the National Research Foundation (NRF disclaimer: Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regards thereto). Nicole van der Merwe received a study bursary from the Technology for Innovation Agency (TIA). LR Fisher is thanked for research assistance. Dr Helen Muir is acknowledged for patient referral during the implementation phase of this translational research study, following attendance of the 6th Applied Genetics Workshop in October 2011 where the initial results obtained in the validation data set were presented. Dr Frans Cronje is acknowledged for assisting with the clinical integration of the data."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025